Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Lynda E. Polgreen's publication output changed over time?
ScholarIQpublication output · 2008–2022
Output grew0% over the shown period — from 1 works in 2008 to 1 in 2022.
1
1
1
2
1
1
1
2
1
200820102013201420152017202020212022
What are the most-cited papers on Lynda E. Polgreen?
ScholarIQmost cited works
Diagnosis and Management of Osteopetrosis: Consensus Guidelines From the Osteopetrosis Working Group
Calvin C. Wu, Michael J. Econs, Linda A. DiMeglio, Karl Insogna, Michael A. Levine, Paul J. Orchard, Weston P. Miller, Anna Petryk, Eric T. Rush, Dolores Shoback, Leanne M. Ward, Lynda E. Polgreen
The Journal of Clinical Endocrinology & Metabolism. 2017243 CitationsOPEN ACCESS
Once-daily, subcutaneous vosoritide therapy in children with achondroplasia: a randomised, double-blind, phase 3, placebo-controlled, multicentre trial
Ravi Savarirayan, Louise Tofts, Melita Irving, William R. Wilcox, Carlos A. Bacino, Julie Hoover‐Fong, Rosendo Ullot Font, Paul Harmatz, Frank Rutsch, Michael B. Bober, Lynda E. Polgreen, Ignacio Ginebreda, Klaus Mohnike, Joel Charrow, Daniel G. Hoernschemeyer, Keiichi Ozono, Yasemin Alanay, Paul Arundel, Shoji Kagami, Natsuo Yasui, Klane K. White, Howard M. Saal, Antonio Leiva‐Gea, Felipe Luna-González, Hiroshi Mochizuki, Donald Basel, Dania M Porco, Kala Jayaram, Elena Fisheleva, Alice Huntsman-Labed, Jonathan Day
The Lancet. 2020200 Citations
Safe and persistent growth-promoting effects of vosoritide in children with achondroplasia: 2-year results from an open-label, phase 3 extension study
Ravi Savarirayan, Louise Tofts, Melita Irving, William R. Wilcox, Carlos A. Bacino, Julie Hoover‐Fong, Rosendo Ullot Font, Paul Harmatz, Frank Rutsch, Michael B. Bober, Lynda E. Polgreen, Ignacio Ginebreda, Klaus Mohnike, Joel Charrow, Daniel G. Hoernschemeyer, Keiichi Ozono, Yasemin Alanay, Paul Arundel, Yumiko Kotani, Natsuo Yasui, Klane K. White, Howard M. Saal, Antonio Leiva‐Gea, Felipe Luna-González, Hiroshi Mochizuki, Donald Basel, Dania M Porco, Kala Jayaram, Elena Fisheleva, Alice Huntsman-Labed, Jonathan Day
S187186932. 2021101 CitationsOPEN ACCESS
Screening, prevention and management of osteoporosis and bone loss in adult and pediatric hematopoietic cell transplant recipients
Brian McClune, Lynda E. Polgreen, Lynn A. Burmeister, Anne Blaes, Daniel A. Mulrooney, Linda J. Burns, Navneet S. Majhail
S183182149. 201095 Citations
Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement
Christiane S. Hampe, Jacob Wesley, Troy C. Lund, Paul J. Orchard, Lynda E. Polgreen, Julie B. Eisengart, Linda K. McLoon, Sebahattin Cüreoğlu, Patricia A. Schachern, R. Scott McIvor
S4210236520. 202193 CitationsOPEN ACCESS
Related on ScholarIQ
UCLA Medical Center
Institution
Diagnosis and Management of Osteopetrosis: Consensus Guidelines From the Osteopetrosis Working Group
Paper
Once-daily, subcutaneous vosoritide therapy in children with achondroplasia: a randomised, double-blind, phase 3, placebo-controlled, multicentre trial
Paper
Safe and persistent growth-promoting effects of vosoritide in children with achondroplasia: 2-year results from an open-label, phase 3 extension study
Paper
Screening, prevention and management of osteoporosis and bone loss in adult and pediatric hematopoietic cell transplant recipients
Paper
Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement
Paper